Patents by Inventor Per Erik Andrén

Per Erik Andrén has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8663959
    Abstract: Methods and devices for preparing a biological sample for analysis are described. The biological sample from an organism has at least macromolecule having a primary structure that naturally degrades after the sample is removed from the organism. The method includes causing the biological sample to adopt a shape to permit rapid and uniform heating. The shaped sample is then rapidly and uniformly heated, thereby altering a secondary structure of the macromolecule while preserving its primary structure.
    Type: Grant
    Filed: August 28, 2006
    Date of Patent: March 4, 2014
    Assignee: Denator Aktiebola
    Inventors: Karl Sköld, Marcus Svensson, Göran Palmers, Per Erik Andrén
  • Patent number: 7332503
    Abstract: New aporphine derivatives are disclosed which have formula (I) and the physiologically acceptable salts thereof. Said derivatives may be used for the treatment of Parkinson's disease, hemicrania, restless legs syndrome (RLS), sexual dysfunction in men and women, hyperprolactemia and psychotic disorders, and/or evaluation of Parkinson's disease. Processes for the preparation of such derivatives are also disclosed.
    Type: Grant
    Filed: February 22, 2005
    Date of Patent: February 19, 2008
    Assignee: Axon Biochemicals B.V.
    Inventors: Hakan Wikstrom, Durk Dijkstra, Thomas Cremers, Per Erik Andren, Sandrine Marchais, Ulrik Jurva
  • Patent number: 7238705
    Abstract: New aporphine derivatives are disclosed which have formula (I) and the physiologically acceptable salts thereof. Said derivatives may be used for the treatment of Parkinson's disease, hemicrania, restless legs syndrome (RLS), sexual dysfunction in men and women, hyperprolactemia and psychotic disorders, and/or evaluation of Parkinson's disease. Processes for the preparation of such derivatives are also disclosed.
    Type: Grant
    Filed: July 20, 2001
    Date of Patent: July 3, 2007
    Assignee: Axon Biochemicals B.V.
    Inventors: Hakan Wikstrom, Durk Dijkstra, Thomas Cremers, Per Erik Andren, Sandrine Marchais, Ulrik Jurva
  • Publication number: 20040018956
    Abstract: New aporphine derivatives are disclosed which have formula (I) and the physiologically acceptable salts thereof. Said derivatives may be used for the treatment of Parkinson's disease, hemicrania, restless legs syndrome (RLS), sexual dysfunction in men and women, hyperprolactemia and psychotic disorders, and/or evaluation of Parkinson's disease. Processes for the preparation of such derivatives are also disclosed.
    Type: Application
    Filed: July 15, 2003
    Publication date: January 29, 2004
    Inventors: Hakan Wikstrom, Durk Dijkstra, Thomas Cremers, Per Erik Andren, Sandrine Marchais, Ulrik Jurva
  • Patent number: 6291494
    Abstract: The invention relates to 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins having general formula (1): wherein R1 and R2, which may be identical or different, are selected from the group consisting of a hydrogen atom, alkyl or haloalkyl groups of 1 to 7 carbon atoms, (alkyl)cycloalkyl groups of 3 to 7 carbon atoms, alkenyl or alkynyl groups of 3 to 6 carbon atoms, arylalkyl having 1 to 3 carbon atoms in the alkyl moiety, while the aryl nucleus may be substituted; and n and m are 1 or 2; and the enantiomers and the acid addition salts thereof, pharmaceutical compositions containing them and their use in the preparation of medicaments having an effect on the dopaminergic system of the central nervous system and/or the circulation.
    Type: Grant
    Filed: February 9, 2001
    Date of Patent: September 18, 2001
    Inventors: Håkan Vilhelm Wikström, Per Erik Andrén, Per Arvid Emil Carlsson, Durk Dijkstra, Lars Gunne, Leonard Alexander Van Vliet